- Home
- GOAI vs CVRX Comparison
GOAI vs CVRX Comparison
Compare GOAI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOAI | CVRX |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 81.3M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GOAI | CVRX |
|---|---|---|
| Price | $1.79 | $2.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 181.6K | ★ 530.3K |
| Earning Date | 04-10-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | $17,037,328.00 | ★ $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 82.59 | 10.45 |
| 52 Week Low | $1.42 | $2.20 |
| 52 Week High | $6.67 | $11.30 |
Technical Indicators
Market Signals| Indicator | GOAI | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 34.62 |
| Support Level | $1.62 | $2.20 |
| Resistance Level | $2.66 | $3.19 |
| Average True Range (ATR) | 0.32 | 0.19 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 3.77 | 4.84 |
Price Performance
Historical ComparisonAbout GOAI Eva Live Inc. Common Stock
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.